Blogger's Note: 'tag' line includes breast cancer only; study included few ovarian cancer patients
Conclusions
In conclusion, our results suggest that
pharmaceutical care for patients with breast and ovarian cancer is
feasible and may
have an impact on PROs as particularly indicated by
significant improvements of the antiemetic response and patient
satisfaction.
Although there is no doubt that a higher awareness of
drug-related problems is beneficial, final conclusions on the
effectiveness
of a new health care intervention can only be drawn when
studied in a randomized trial. Therefore, our data may serve as a
valuable basis for planning a large randomized
multicenter trial.
